Related references
Note: Only part of the references are listed.Low solubility in drug development: de-convoluting the relative importance of solvation and crystal packing
Robert Docherty et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2015)
Advancing the Drug Discovery and Development Process
K. C. Nicolaou
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Novel tactics for designing water-soluble molecules in drug discovery
Michael A. Walker
EXPERT OPINION ON DRUG DISCOVERY (2014)
Cubanes in Medicinal Chemistry: Synthesis of Functionalized Building Blocks
Joanna Wlochal et al.
ORGANIC LETTERS (2014)
Tyrosine Kinase Inhibitors: Views of Selectivity, Sensitivity, and Clinical Performance
Alexander Levitzki
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
Antonia F. Stepan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder
Ernesto Callegari et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
A novel synthesis of imatinib and its intermediates
Haiyan Liu et al.
MONATSHEFTE FUR CHEMIE (2010)
The impact of aromatic ring count on compound developability - are too many aromatic rings a liability in drug design?
Timothy J. Ritchie et al.
DRUG DISCOVERY TODAY (2009)
Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction Approaches
Natilie A. Hosea et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Frank Lovering et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Synthesis of imatinib: a convergent approach revisited
Andrey S. Ivanov et al.
MONATSHEFTE FUR CHEMIE (2009)
A facile total synthesis of imatinib base and its analogues
Yi-Feng liu et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2008)
Optimization of the conditions for copper-mediated N-arylation of heteroarylamines
Yifeng Liu et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2007)
Treatment for chronic myelogenous leukemia: the long road to imatinib
Tony Hunter
JOURNAL OF CLINICAL INVESTIGATION (2007)
Synthesis and positron emission tomography studies of carbon-11-labeled imatinib (Gleevec)
Kun-Eek Kil et al.
NUCLEAR MEDICINE AND BIOLOGY (2007)
Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia
Sandra W. Cowan-Jacob et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2007)
Photocurable hard and porous biomaterials from ROMP precursors cross-linked with diyl radicals
E Enholm et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Development of versatile cis- and trans-dicarbon-substituted chiral cyclopropane units:: Synthesis of (1S,2R)- and (1R,2R)-2-aminomethyl-1-(1H-imidazol-4-yl)cyclopropanes and their enantiomers as conformationally restricted analogues of histamine
Y Kazuta et al.
JOURNAL OF ORGANIC CHEMISTRY (2002)
Share Paper
